Cas:1197-66-6 2,2,6,6-Tetramethyltetrahydro-4H-pyran-4-one manufacturer & supplier

We serve Chemical Name:2,2,6,6-Tetramethyltetrahydro-4H-pyran-4-one CAS:1197-66-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2,2,6,6-Tetramethyltetrahydro-4H-pyran-4-one

Chemical Name:2,2,6,6-Tetramethyltetrahydro-4H-pyran-4-one
CAS.NO:1197-66-6
Synonyms:2,2,6,6-Tetramethyltetrahydro-4H-pyran-4-one;2,2,6,6-Tetramethyl-2H-3,5,6-trihydropyran-4-one;QC-3644;Tetrahydro-2,2,6,6-tetramethylpyran-4-one;4H-Pyran-4-one, tetrahydro-2,2,6,6-tetramethyl-;2,2,6,6-tetramethyltetrahydro-4 H-pyran-4-one;2,2,6,6-Tetramethyl-tetrahydro-pyran-4-on;2,2,6,6-tetramethyltetrahydropyran-4-one;RW4043
Molecular Formula:C9H16O2
Molecular Weight:156.222
HS Code:2932999099

Physical and Chemical Properties:
Melting point:N/A
Boiling point:198.1±15.0 °C at 760 mmHg
Density:0.9±0.1 g/cm3
Index of Refraction:1.422
PSA:26.30000
Exact Mass:156.115036
LogP:1.28

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2,2,6,6-Tetramethyltetrahydro-4H-pyran-4-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,RW4043 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,2,6,6-Tetramethyl-2H-3,5,6-trihydropyran-4-one Use and application,2,2,6,6-tetramethyltetrahydropyran-4-one technical grade,usp/ep/jp grade.


Related News: We are committed to bringing safe, effective vaccines to Ireland and other markets as quickly as possible, and Charles River will continue to be an important partner in this regard.” 3-[[[[3-[(aminoiminomethyl)amino]phenyl]amino]carbonyl]amino]benzenepropanoic acid manufacturers For skin rash, the difference in response rates for anifrolumab versus placebo at week 52 were 13.5% SLE Disease Activity Index (SLEDAI), 15.5% British Isles Lupus Assessment Group index (BILAG) and 15.6% modified Cutaneous Lupus Erythematosus Disease Area and Severity Index (mCLASI). For arthritis, differences in response rates were 8.2% SLEDAI, 11.8% BILAG and 12.6% joint response. 3-(3-methyl-1-nitrobutan-2-yl)pentane-2,4-dione suppliers As we expand our offering into the US and beyond, NOVA aims to become the go-to partner for pharma and biotech companies for in silico clinical trial support. I am delighted to welcome Grégoire to the Novadiscovery team and look forward to working closely with him.” (dimethylphosphinodithioato)(η-mesitylene)pyridineruthenium(II)tetraphenylborate vendor & factory.